semaglutide who makes Novo Nordisk strikes back at Hims & Hers “We distance ourselves from the irresponsible and misleading advertisements” Novo Nordisk's weight-loss pill wins

Trivedi MS, Arber N, Friedman E, Garber JE, Holcomb K, Horowitz NS, et al

Cycle Duration and Monitoring Typical cycle: 1224 weeks Monitoring: baseline and 1012 week IGF-1 measurement is the most common biomarker Washout: 48 weeks between cycles is standard practitioner practice Contraindications Active malignancy GH/IGF-1 axis elevation is a theoretical oncogenic concern Diabetes mellitus GH elevates insulin resistance

Whole cell GSH abundance (bottom left) and fold change in cell number (log 2 ) of HEK-293T cells expressing a vector control or engineered GshF cDNA treated with indicated BSO concentrations for 5 days (bottom right)

New studies on microneedling with topical lightening agents rucinol and sophora-alpha showed significant improvement in depigmentation